Growth hormone disorder is a rare type of condition that is typically characterized by inadequate secretion of growth hormone (GH) from the anterior pituitary gland. This kind of hormones can be present since birth and cause serious genetic mutation or structural defects in the brain. The growth hormone disorders can be acquired in the later years due to the presence of severe infection, trauma among others. The risk of passing the abnormal gene from affected parent to offspring is 50% for each pregnancy.
The global market for Growth Hormone Disorder Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Growth Hormone Disorder Treatment players cover Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Growth Hormone Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Growth Hormone Disorder Treatment market, with both quantitative and qualitative data, to help readers understand how the Growth Hormone Disorder Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Growth Hormone Disorder Treatment market and forecasts the market size by Type (Growth Hormone Stimulator and Growth Hormone Inhibitor,), by Application (Dwarfism, Gigantism and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Growth Hormone Stimulator
Growth Hormone Inhibitor
Segmentation by application
Dwarfism
Gigantism
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Teva Pharmaceutical Industries Ltd
Amneal Pharmaceutical Inc
Mayne Pharma Group Limited
Merck KGaA
Sanofi
Sun Pharmaceutical Industries Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Abbott
PT. Daewoong Pharmaceutical Company
Genentech, Inc
Bausch Health Companies Inc
Lilly
Ipsen Pharma
Ferring B.V
Chapter Introduction
Chapter 1: Scope of Growth Hormone Disorder Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Growth Hormone Disorder Treatment market size (sales and revenue) and CAGR, Growth Hormone Disorder Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Growth Hormone Disorder Treatment sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Growth Hormone Disorder Treatment sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Growth Hormone Disorder Treatment market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA, Sanofi, Sun Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche Ltd and Abbott, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Growth Hormone Disorder Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Growth Hormone Disorder Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Growth Hormone Disorder Treatment by Country/Region, 2017, 2022 & 2028
2.2 Growth Hormone Disorder Treatment Segment by Type
2.2.1 Growth Hormone Stimulator
2.2.2 Growth Hormone Inhibitor
2.3 Growth Hormone Disorder Treatment Sales by Type
2.3.1 Global Growth Hormone Disorder Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Growth Hormone Disorder Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Growth Hormone Disorder Treatment Sale Price by Type (2017-2022)
2.4 Growth Hormone Disorder Treatment Segment by Application
2.4.1 Dwarfism
2.4.2 Gigantism
2.4.3 Other
2.5 Growth Hormone Disorder Treatment Sales by Application
2.5.1 Global Growth Hormone Disorder Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Growth Hormone Disorder Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Growth Hormone Disorder Treatment Sale Price by Application (2017-2022)
3 Global Growth Hormone Disorder Treatment by Company
3.1 Global Growth Hormone Disorder Treatment Breakdown Data by Company
3.1.1 Global Growth Hormone Disorder Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Growth Hormone Disorder Treatment Sales Market Share by Company (2020-2022)
3.2 Global Growth Hormone Disorder Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Growth Hormone Disorder Treatment Revenue by Company (2020-2022)
3.2.2 Global Growth Hormone Disorder Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Growth Hormone Disorder Treatment Sale Price by Company
3.4 Key Manufacturers Growth Hormone Disorder Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Growth Hormone Disorder Treatment Product Location Distribution
3.4.2 Players Growth Hormone Disorder Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Growth Hormone Disorder Treatment by Geographic Region
4.1 World Historic Growth Hormone Disorder Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Growth Hormone Disorder Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Growth Hormone Disorder Treatment Annual Revenue by Geographic Region
4.2 World Historic Growth Hormone Disorder Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Growth Hormone Disorder Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Growth Hormone Disorder Treatment Annual Revenue by Country/Region
4.3 Americas Growth Hormone Disorder Treatment Sales Growth
4.4 APAC Growth Hormone Disorder Treatment Sales Growth
4.5 Europe Growth Hormone Disorder Treatment Sales Growth
4.6 Middle East & Africa Growth Hormone Disorder Treatment Sales Growth
5 Americas
5.1 Americas Growth Hormone Disorder Treatment Sales by Country
5.1.1 Americas Growth Hormone Disorder Treatment Sales by Country (2017-2022)
5.1.2 Americas Growth Hormone Disorder Treatment Revenue by Country (2017-2022)
5.2 Americas Growth Hormone Disorder Treatment Sales by Type
5.3 Americas Growth Hormone Disorder Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Growth Hormone Disorder Treatment Sales by Region
6.1.1 APAC Growth Hormone Disorder Treatment Sales by Region (2017-2022)
6.1.2 APAC Growth Hormone Disorder Treatment Revenue by Region (2017-2022)
6.2 APAC Growth Hormone Disorder Treatment Sales by Type
6.3 APAC Growth Hormone Disorder Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Growth Hormone Disorder Treatment by Country
7.1.1 Europe Growth Hormone Disorder Treatment Sales by Country (2017-2022)
7.1.2 Europe Growth Hormone Disorder Treatment Revenue by Country (2017-2022)
7.2 Europe Growth Hormone Disorder Treatment Sales by Type
7.3 Europe Growth Hormone Disorder Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Growth Hormone Disorder Treatment by Country
8.1.1 Middle East & Africa Growth Hormone Disorder Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Growth Hormone Disorder Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Growth Hormone Disorder Treatment Sales by Type
8.3 Middle East & Africa Growth Hormone Disorder Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Growth Hormone Disorder Treatment
10.3 Manufacturing Process Analysis of Growth Hormone Disorder Treatment
10.4 Industry Chain Structure of Growth Hormone Disorder Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Growth Hormone Disorder Treatment Distributors
11.3 Growth Hormone Disorder Treatment Customer
12 World Forecast Review for Growth Hormone Disorder Treatment by Geographic Region
12.1 Global Growth Hormone Disorder Treatment Market Size Forecast by Region
12.1.1 Global Growth Hormone Disorder Treatment Forecast by Region (2023-2028)
12.1.2 Global Growth Hormone Disorder Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Growth Hormone Disorder Treatment Forecast by Type
12.7 Global Growth Hormone Disorder Treatment Forecast by Application
13 Key Players Analysis
13.1 Teva Pharmaceutical Industries Ltd
13.1.1 Teva Pharmaceutical Industries Ltd Company Information
13.1.2 Teva Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Product Offered
13.1.3 Teva Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.1.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.2 Amneal Pharmaceutical Inc
13.2.1 Amneal Pharmaceutical Inc Company Information
13.2.2 Amneal Pharmaceutical Inc Growth Hormone Disorder Treatment Product Offered
13.2.3 Amneal Pharmaceutical Inc Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amneal Pharmaceutical Inc Main Business Overview
13.2.5 Amneal Pharmaceutical Inc Latest Developments
13.3 Mayne Pharma Group Limited
13.3.1 Mayne Pharma Group Limited Company Information
13.3.2 Mayne Pharma Group Limited Growth Hormone Disorder Treatment Product Offered
13.3.3 Mayne Pharma Group Limited Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mayne Pharma Group Limited Main Business Overview
13.3.5 Mayne Pharma Group Limited Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Growth Hormone Disorder Treatment Product Offered
13.4.3 Merck KGaA Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Growth Hormone Disorder Treatment Product Offered
13.5.3 Sanofi Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Sun Pharmaceutical Industries Ltd
13.6.1 Sun Pharmaceutical Industries Ltd Company Information
13.6.2 Sun Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Product Offered
13.6.3 Sun Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sun Pharmaceutical Industries Ltd Main Business Overview
13.6.5 Sun Pharmaceutical Industries Ltd Latest Developments
13.7 Novartis AG
13.7.1 Novartis AG Company Information
13.7.2 Novartis AG Growth Hormone Disorder Treatment Product Offered
13.7.3 Novartis AG Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis AG Main Business Overview
13.7.5 Novartis AG Latest Developments
13.8 F. Hoffmann-La Roche Ltd
13.8.1 F. Hoffmann-La Roche Ltd Company Information
13.8.2 F. Hoffmann-La Roche Ltd Growth Hormone Disorder Treatment Product Offered
13.8.3 F. Hoffmann-La Roche Ltd Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.8.5 F. Hoffmann-La Roche Ltd Latest Developments
13.9 Abbott
13.9.1 Abbott Company Information
13.9.2 Abbott Growth Hormone Disorder Treatment Product Offered
13.9.3 Abbott Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Abbott Main Business Overview
13.9.5 Abbott Latest Developments
13.10 PT. Daewoong Pharmaceutical Company
13.10.1 PT. Daewoong Pharmaceutical Company Company Information
13.10.2 PT. Daewoong Pharmaceutical Company Growth Hormone Disorder Treatment Product Offered
13.10.3 PT. Daewoong Pharmaceutical Company Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 PT. Daewoong Pharmaceutical Company Main Business Overview
13.10.5 PT. Daewoong Pharmaceutical Company Latest Developments
13.11 Genentech, Inc
13.11.1 Genentech, Inc Company Information
13.11.2 Genentech, Inc Growth Hormone Disorder Treatment Product Offered
13.11.3 Genentech, Inc Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Genentech, Inc Main Business Overview
13.11.5 Genentech, Inc Latest Developments
13.12 Bausch Health Companies Inc
13.12.1 Bausch Health Companies Inc Company Information
13.12.2 Bausch Health Companies Inc Growth Hormone Disorder Treatment Product Offered
13.12.3 Bausch Health Companies Inc Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bausch Health Companies Inc Main Business Overview
13.12.5 Bausch Health Companies Inc Latest Developments
13.13 Lilly
13.13.1 Lilly Company Information
13.13.2 Lilly Growth Hormone Disorder Treatment Product Offered
13.13.3 Lilly Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Lilly Main Business Overview
13.13.5 Lilly Latest Developments
13.14 Ipsen Pharma
13.14.1 Ipsen Pharma Company Information
13.14.2 Ipsen Pharma Growth Hormone Disorder Treatment Product Offered
13.14.3 Ipsen Pharma Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Ipsen Pharma Main Business Overview
13.14.5 Ipsen Pharma Latest Developments
13.15 Ferring B.V
13.15.1 Ferring B.V Company Information
13.15.2 Ferring B.V Growth Hormone Disorder Treatment Product Offered
13.15.3 Ferring B.V Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Ferring B.V Main Business Overview
13.15.5 Ferring B.V Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Growth Hormone Disorder Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Growth Hormone Disorder Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Growth Hormone Stimulator
Table 4. Major Players of Growth Hormone Inhibitor
Table 5. Global Growth Hormone Disorder Treatment Sales by Type (2017-2022) & (K Units)
Table 6. Global Growth Hormone Disorder Treatment Sales Market Share by Type (2017-2022)
Table 7. Global Growth Hormone Disorder Treatment Revenue by Type (2017-2022) & ($ million)
Table 8. Global Growth Hormone Disorder Treatment Revenue Market Share by Type (2017-2022)
Table 9. Global Growth Hormone Disorder Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Growth Hormone Disorder Treatment Sales by Application (2017-2022) & (K Units)
Table 11. Global Growth Hormone Disorder Treatment Sales Market Share by Application (2017-2022)
Table 12. Global Growth Hormone Disorder Treatment Revenue by Application (2017-2022)
Table 13. Global Growth Hormone Disorder Treatment Revenue Market Share by Application (2017-2022)
Table 14. Global Growth Hormone Disorder Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Growth Hormone Disorder Treatment Sales by Company (2020-2022) & (K Units)
Table 16. Global Growth Hormone Disorder Treatment Sales Market Share by Company (2020-2022)
Table 17. Global Growth Hormone Disorder Treatment Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Growth Hormone Disorder Treatment Revenue Market Share by Company (2020-2022)
Table 19. Global Growth Hormone Disorder Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Growth Hormone Disorder Treatment Producing Area Distribution and Sales Area
Table 21. Players Growth Hormone Disorder Treatment Products Offered
Table 22. Growth Hormone Disorder Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Growth Hormone Disorder Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Growth Hormone Disorder Treatment Sales Market Share Geographic Region (2017-2022)
Table 27. Global Growth Hormone Disorder Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Growth Hormone Disorder Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Growth Hormone Disorder Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Growth Hormone Disorder Treatment Sales Market Share by Country/Region (2017-2022)
Table 31. Global Growth Hormone Disorder Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Growth Hormone Disorder Treatment Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Growth Hormone Disorder Treatment Sales by Country (2017-2022) & (K Units)
Table 34. Americas Growth Hormone Disorder Treatment Sales Market Share by Country (2017-2022)
Table 35. Americas Growth Hormone Disorder Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Growth Hormone Disorder Treatment Revenue Market Share by Country (2017-2022)
Table 37. Americas Growth Hormone Disorder Treatment Sales by Type (2017-2022) & (K Units)
Table 38. Americas Growth Hormone Disorder Treatment Sales Market Share by Type (2017-2022)
Table 39. Americas Growth Hormone Disorder Treatment Sales by Application (2017-2022) & (K Units)
Table 40. Americas Growth Hormone Disorder Treatment Sales Market Share by Application (2017-2022)
Table 41. APAC Growth Hormone Disorder Treatment Sales by Region (2017-2022) & (K Units)
Table 42. APAC Growth Hormone Disorder Treatment Sales Market Share by Region (2017-2022)
Table 43. APAC Growth Hormone Disorder Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Growth Hormone Disorder Treatment Revenue Market Share by Region (2017-2022)
Table 45. APAC Growth Hormone Disorder Treatment Sales by Type (2017-2022) & (K Units)
Table 46. APAC Growth Hormone Disorder Treatment Sales Market Share by Type (2017-2022)
Table 47. APAC Growth Hormone Disorder Treatment Sales by Application (2017-2022) & (K Units)
Table 48. APAC Growth Hormone Disorder Treatment Sales Market Share by Application (2017-2022)
Table 49. Europe Growth Hormone Disorder Treatment Sales by Country (2017-2022) & (K Units)
Table 50. Europe Growth Hormone Disorder Treatment Sales Market Share by Country (2017-2022)
Table 51. Europe Growth Hormone Disorder Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Growth Hormone Disorder Treatment Revenue Market Share by Country (2017-2022)
Table 53. Europe Growth Hormone Disorder Treatment Sales by Type (2017-2022) & (K Units)
Table 54. Europe Growth Hormone Disorder Treatment Sales Market Share by Type (2017-2022)
Table 55. Europe Growth Hormone Disorder Treatment Sales by Application (2017-2022) & (K Units)
Table 56. Europe Growth Hormone Disorder Treatment Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Growth Hormone Disorder Treatment Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Growth Hormone Disorder Treatment Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Growth Hormone Disorder Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Growth Hormone Disorder Treatment Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Growth Hormone Disorder Treatment Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Growth Hormone Disorder Treatment Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Growth Hormone Disorder Treatment Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Growth Hormone Disorder Treatment Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Growth Hormone Disorder Treatment
Table 66. Key Market Challenges & Risks of Growth Hormone Disorder Treatment
Table 67. Key Industry Trends of Growth Hormone Disorder Treatment
Table 68. Growth Hormone Disorder Treatment Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Growth Hormone Disorder Treatment Distributors List
Table 71. Growth Hormone Disorder Treatment Customer List
Table 72. Global Growth Hormone Disorder Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Growth Hormone Disorder Treatment Sales Market Forecast by Region
Table 74. Global Growth Hormone Disorder Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Growth Hormone Disorder Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Growth Hormone Disorder Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Growth Hormone Disorder Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Growth Hormone Disorder Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Growth Hormone Disorder Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Growth Hormone Disorder Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Growth Hormone Disorder Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Growth Hormone Disorder Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Growth Hormone Disorder Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Growth Hormone Disorder Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Growth Hormone Disorder Treatment Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Growth Hormone Disorder Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Growth Hormone Disorder Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Growth Hormone Disorder Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Growth Hormone Disorder Treatment Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Growth Hormone Disorder Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Growth Hormone Disorder Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 92. Teva Pharmaceutical Industries Ltd Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Product Offered
Table 94. Teva Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Teva Pharmaceutical Industries Ltd Main Business
Table 96. Teva Pharmaceutical Industries Ltd Latest Developments
Table 97. Amneal Pharmaceutical Inc Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 98. Amneal Pharmaceutical Inc Growth Hormone Disorder Treatment Product Offered
Table 99. Amneal Pharmaceutical Inc Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Amneal Pharmaceutical Inc Main Business
Table 101. Amneal Pharmaceutical Inc Latest Developments
Table 102. Mayne Pharma Group Limited Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 103. Mayne Pharma Group Limited Growth Hormone Disorder Treatment Product Offered
Table 104. Mayne Pharma Group Limited Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Mayne Pharma Group Limited Main Business
Table 106. Mayne Pharma Group Limited Latest Developments
Table 107. Merck KGaA Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck KGaA Growth Hormone Disorder Treatment Product Offered
Table 109. Merck KGaA Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Merck KGaA Main Business
Table 111. Merck KGaA Latest Developments
Table 112. Sanofi Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 113. Sanofi Growth Hormone Disorder Treatment Product Offered
Table 114. Sanofi Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Sanofi Main Business
Table 116. Sanofi Latest Developments
Table 117. Sun Pharmaceutical Industries Ltd Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 118. Sun Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Product Offered
Table 119. Sun Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Sun Pharmaceutical Industries Ltd Main Business
Table 121. Sun Pharmaceutical Industries Ltd Latest Developments
Table 122. Novartis AG Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 123. Novartis AG Growth Hormone Disorder Treatment Product Offered
Table 124. Novartis AG Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Novartis AG Main Business
Table 126. Novartis AG Latest Developments
Table 127. F. Hoffmann-La Roche Ltd Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 128. F. Hoffmann-La Roche Ltd Growth Hormone Disorder Treatment Product Offered
Table 129. F. Hoffmann-La Roche Ltd Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. F. Hoffmann-La Roche Ltd Main Business
Table 131. F. Hoffmann-La Roche Ltd Latest Developments
Table 132. Abbott Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 133. Abbott Growth Hormone Disorder Treatment Product Offered
Table 134. Abbott Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Abbott Main Business
Table 136. Abbott Latest Developments
Table 137. PT. Daewoong Pharmaceutical Company Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 138. PT. Daewoong Pharmaceutical Company Growth Hormone Disorder Treatment Product Offered
Table 139. PT. Daewoong Pharmaceutical Company Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. PT. Daewoong Pharmaceutical Company Main Business
Table 141. PT. Daewoong Pharmaceutical Company Latest Developments
Table 142. Genentech, Inc Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 143. Genentech, Inc Growth Hormone Disorder Treatment Product Offered
Table 144. Genentech, Inc Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Genentech, Inc Main Business
Table 146. Genentech, Inc Latest Developments
Table 147. Bausch Health Companies Inc Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 148. Bausch Health Companies Inc Growth Hormone Disorder Treatment Product Offered
Table 149. Bausch Health Companies Inc Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Bausch Health Companies Inc Main Business
Table 151. Bausch Health Companies Inc Latest Developments
Table 152. Lilly Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 153. Lilly Growth Hormone Disorder Treatment Product Offered
Table 154. Lilly Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Lilly Main Business
Table 156. Lilly Latest Developments
Table 157. Ipsen Pharma Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 158. Ipsen Pharma Growth Hormone Disorder Treatment Product Offered
Table 159. Ipsen Pharma Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Ipsen Pharma Main Business
Table 161. Ipsen Pharma Latest Developments
Table 162. Ferring B.V Basic Information, Growth Hormone Disorder Treatment Manufacturing Base, Sales Area and Its Competitors
Table 163. Ferring B.V Growth Hormone Disorder Treatment Product Offered
Table 164. Ferring B.V Growth Hormone Disorder Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Ferring B.V Main Business
Table 166. Ferring B.V Latest Developments
List of Figures
Figure 1. Picture of Growth Hormone Disorder Treatment
Figure 2. Growth Hormone Disorder Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Growth Hormone Disorder Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Growth Hormone Disorder Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Growth Hormone Disorder Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Growth Hormone Stimulator
Figure 10. Product Picture of Growth Hormone Inhibitor
Figure 11. Global Growth Hormone Disorder Treatment Sales Market Share by Type in 2021
Figure 12. Global Growth Hormone Disorder Treatment Revenue Market Share by Type (2017-2022)
Figure 13. Growth Hormone Disorder Treatment Consumed in Dwarfism
Figure 14. Global Growth Hormone Disorder Treatment Market: Dwarfism (2017-2022) & (K Units)
Figure 15. Growth Hormone Disorder Treatment Consumed in Gigantism
Figure 16. Global Growth Hormone Disorder Treatment Market: Gigantism (2017-2022) & (K Units)
Figure 17. Growth Hormone Disorder Treatment Consumed in Other
Figure 18. Global Growth Hormone Disorder Treatment Market: Other (2017-2022) & (K Units)
Figure 19. Global Growth Hormone Disorder Treatment Sales Market Share by Application (2017-2022)
Figure 20. Global Growth Hormone Disorder Treatment Revenue Market Share by Application in 2021
Figure 21. Growth Hormone Disorder Treatment Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Growth Hormone Disorder Treatment Revenue Market Share by Company in 2021
Figure 23. Global Growth Hormone Disorder Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Growth Hormone Disorder Treatment Revenue Market Share by Geographic Region in 2021
Figure 25. Global Growth Hormone Disorder Treatment Sales Market Share by Region (2017-2022)
Figure 26. Global Growth Hormone Disorder Treatment Revenue Market Share by Country/Region in 2021
Figure 27. Americas Growth Hormone Disorder Treatment Sales 2017-2022 (K Units)
Figure 28. Americas Growth Hormone Disorder Treatment Revenue 2017-2022 ($ Millions)
Figure 29. APAC Growth Hormone Disorder Treatment Sales 2017-2022 (K Units)
Figure 30. APAC Growth Hormone Disorder Treatment Revenue 2017-2022 ($ Millions)
Figure 31. Europe Growth Hormone Disorder Treatment Sales 2017-2022 (K Units)
Figure 32. Europe Growth Hormone Disorder Treatment Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Growth Hormone Disorder Treatment Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Growth Hormone Disorder Treatment Revenue 2017-2022 ($ Millions)
Figure 35. Americas Growth Hormone Disorder Treatment Sales Market Share by Country in 2021
Figure 36. Americas Growth Hormone Disorder Treatment Revenue Market Share by Country in 2021
Figure 37. United States Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Growth Hormone Disorder Treatment Sales Market Share by Region in 2021
Figure 42. APAC Growth Hormone Disorder Treatment Revenue Market Share by Regions in 2021
Figure 43. China Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Growth Hormone Disorder Treatment Sales Market Share by Country in 2021
Figure 50. Europe Growth Hormone Disorder Treatment Revenue Market Share by Country in 2021
Figure 51. Germany Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Growth Hormone Disorder Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle